- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-792/19: Order of the General Court of 4 December 2020 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA) (EU trade mark — Opposition proceedings — Withdrawal of the opposition — No need to adjudicate)
ECLI:EU:UNKNOWN:62019TB0792
62019TB0792
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 35/50
(Case T-792/19) (*)
(EU trade mark - Opposition proceedings - Withdrawal of the opposition - No need to adjudicate)
(2021/C 35/66)
Language of the case: German
Parties
Applicant: Agepha Pharma s.r.o. (Senec, Slovakia) (represented by: D. Göbel, lawyer)
Defendant: European Union Intellectual Property Office (represented by: D. Walicka, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Apogepha Arzneimittel GmbH (Dresden, Germany) (represented by: A. Marx and R. Kaase, lawyers)
Re:
Action brought against the decision of the Second Board of Appeal of EUIPO of 26 August 2019 (Case R 386/2019-2), relating to opposition proceedings between Apogepha Arzneimittel GmbH and Agepha Pharma s.r.o.
Operative part of the order
1.There is no longer any need to adjudicate on the action.
2.Agepha Pharma s.r.o and Apogepha Arzneimittel GmbH shall bear their own costs and shall each pay half of the costs incurred by the European Union Intellectual Property Office (EUIPO).
(*) Language of the case: German.
* * *
(1) OJ C 10, 13.1.2020.